Skeletal Related Events, Bone Metastasis and Survival of Prostate Cancer: A Population Based Cohort Study in Denmark (1999 to 2007)

Journal of Urology

Volumn 184, Issue 1, 2010, Pages 162-167

  Nørgaard, Mette ^a   Jensen, Annette Østergaard ^a   Jacobsen, Jacob Bonde ^a   Cetin, Kara ^a   Fryzek, Jon P ^a   Sørensen, Henrik Toft ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

bone and bones; neoplasm metastasis; prognosis; prostate; prostatic neoplasms

Indexed keywords

AGED; ARTICLE; BONE METASTASIS; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER PATIENT; CANCER SURVIVAL; COHORT ANALYSIS; COMORBIDITY; COMPARATIVE STUDY; DEMOGRAPHY; DENMARK; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; SURVIVAL TIME;

AGED; BONE NEOPLASMS; COMORBIDITY; DENMARK; FOLLOW-UP STUDIES; HUMANS; MALE; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; PROSTATIC NEOPLASMS; REGISTRIES; SURVIVAL ANALYSIS;

EID: 77953229266     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2010.03.034     Document Type: Article

References (24)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2007. CA Cancer J Clin 57 (2007) 43
2. Coleman M.P., Quaresma M., Berrino F., et al. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol 9 (2008) 730
3. Horner M.J., Ries L.A.G., Krapcho M., et al. SEER Cancer Statistics Review (1975-2006), National Cancer Institute, Bethesda, Maryland. http://seer.cancer.gov/csr/1975_2006/ based on November 2008 SEER data submission, posted to the SEER web site 2009
4. Damber J.E., and Aus G. Prostate cancer. Lancet 71 (2008) 1710
5. Galasko C.S. Skeletal metastases. Clin Orthop Relat Res 210 (1986) 18
6. Logothetis C.J., Navone N.M., and Lin S.H. Understanding the biology of bone metastases: key to the effective treatment of prostate cancer. Clin Cancer Res 14 (2008) 1599
7. Michaelson M.D., and Smith M.R. Bisphosphonates for treatment and prevention of bone metastases. J Clin Oncol 23 (2005) 8219
8. Coleman R.E. Skeletal complications of malignancy. Cancer 80 (1997) 1588
9. Nelson E.C., Evans C.P., Pan C.X., et al. Prostate cancer and markers of bone metabolism: diagnostic, prognostic, and therapeutic implications. World J Urol 25 (2007) 393
10. Saad F., Lipton A., Cook R., et al. Pathologic fractures correlate with reduced survival in patients with malignant bone disease. Cancer 110 (2007) 1860
11. Oefelein M.G., Ricchiuti V., Conrad W., et al. Skeletal fractures negatively correlate with overall survival in men with prostate cancer. J Urol 168 (2002) 1005
12. Inoue T., Segawa T., Kamba T., et al. Prevalence of skeletal complications and their impact on survival of hormone refractory prostate cancer patients in Japan. Urology 73 (2009) 1104
13. Frank L. Epidemiology. When an entire country is a cohort. Science 287 (2000) 2398
14. Andersen T.F., Madsen M., Jorgensen J., et al. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 46 (1999) 263
15. Charlson M.E., Pompei P., Ales K.L., et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 (1987) 373
16. Thomsen R.W., Hundborg H.H., Lervang H.H., et al. Diabetes and outcome of community-acquired pneumococcal bacteremia: a 10-year population-based cohort study. Diabetes Care 27 (2004) 70
17. Gooley T.A., Leisenring W., Crowley J., et al. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 18 (1999) 695
18. Braithwaite R.S., Col N.F., and Wong J.B. Estimating hip fracture morbidity, mortality and costs. J Am Geriatr Soc 51 (2003) 364
19. Wilchesky M., Tamblyn R.M., and Huang A. Validation of diagnostic codes within medical services claims. J Clin Epidemiol 57 (2004) 131
20. Lund L., Borre M., Jacobsen J., et al. Impact of comorbidity on survival of Danish prostate cancer patients, 1995-2006: a population-based cohort study. Urology 72 (2008) 1258
21. Jensen A.Ø., Nørgaard M., Yong M., et al. Validity of the recorded International Classification of Diseases, 10th edition diagnoses codes of bone metastases and skeletal-related events in breast and prostate cancer patients in the Danish National Registry of Patients. Clin Epidemiol 1 (2009) 101
22. Steinberg E.P., Whittle J., and Anderson G.F. Impact of claims data research on clinical practice. Int J Technol Assess Health Care 6 (1990) 282
23. Glass T.R., Tangen C.M., Crawford E.D., et al. Metastatic carcinoma of the prostate: identifying prognostic groups using recursive partitioning. J Urol 169 (2003) 164
24. Yuen K.Y., Shelley M., Sze W.M., et al. Bisphosphonates for advanced prostate cancer. Cochrane Database Syst Rev 4 (2006) CD006250